Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP323391.RAmLF5cjeCRMqnqPIvuNYI0LpXPR_rm-ykLYaqa__6NXM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP323391.RAmLF5cjeCRMqnqPIvuNYI0LpXPR_rm-ykLYaqa__6NXM130_assertion type Assertion NP323391.RAmLF5cjeCRMqnqPIvuNYI0LpXPR_rm-ykLYaqa__6NXM130_head.
- NP323391.RAmLF5cjeCRMqnqPIvuNYI0LpXPR_rm-ykLYaqa__6NXM130_assertion description "[Evidence demonstrates the utility of anti-CD14 monoclonal antibody therapy in septic shock and the potential value of targeting intracellular kinases to modulate harmful cellular responses during sepsis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP323391.RAmLF5cjeCRMqnqPIvuNYI0LpXPR_rm-ykLYaqa__6NXM130_provenance.
- NP323391.RAmLF5cjeCRMqnqPIvuNYI0LpXPR_rm-ykLYaqa__6NXM130_assertion evidence source_evidence_literature NP323391.RAmLF5cjeCRMqnqPIvuNYI0LpXPR_rm-ykLYaqa__6NXM130_provenance.
- NP323391.RAmLF5cjeCRMqnqPIvuNYI0LpXPR_rm-ykLYaqa__6NXM130_assertion SIO_000772 11445726 NP323391.RAmLF5cjeCRMqnqPIvuNYI0LpXPR_rm-ykLYaqa__6NXM130_provenance.
- NP323391.RAmLF5cjeCRMqnqPIvuNYI0LpXPR_rm-ykLYaqa__6NXM130_assertion wasDerivedFrom befree-2016 NP323391.RAmLF5cjeCRMqnqPIvuNYI0LpXPR_rm-ykLYaqa__6NXM130_provenance.
- NP323391.RAmLF5cjeCRMqnqPIvuNYI0LpXPR_rm-ykLYaqa__6NXM130_assertion wasGeneratedBy ECO_0000203 NP323391.RAmLF5cjeCRMqnqPIvuNYI0LpXPR_rm-ykLYaqa__6NXM130_provenance.